Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gleways M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Rowlinges Life Science

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Gleways M 2mg/500mg Tablet SR

Diabetic patients with type 2 mellitus may be prescribed Glucowin SR tablets (2mg/500mg), a dual-action anti-diabetic medication. This formulation regulates blood glucose by combining two active ingredients. Always ingest this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your individual blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, risking complications including kidney failure, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan that incorporates a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by symptoms like sweating, lightheadedness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects comprise altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated for those with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women must consult their physician prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Primary Ingredients of Gleways M 2mg/500mg Tablet SR

No text provided to rephrase.

Uses of Gleways M 2mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Gleways M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. Gleways M 2mg/500mg Sustained-Release Tablets should be taken with meals.

Common Side effects of Gleways M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gleways M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gleways M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Gleways M 2mg/500mg Tablet SR works:

Gleways M 2mg/500mg Extended-Release tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Gleways M 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gleways M 2mg/500mg SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Gleways M tablets (2mg/500mg) are contraindicated during lactation due to the potential for infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gleways M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Gleways M 2mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Gleways M 2mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Gleways M 2mg/500mg SR tablets at a reduced dosage; its use is contraindicated in cases of severe liver disease.

What if you forget to take Gleways M 2mg/500mg Tablet SR :

Should you forget a Gleways M 2mg/500mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gleways M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gleways M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Gleways M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gleways M 2mg/500mg Tablet SR and seek immediate medical attention.
Gleways M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gleways M 2mg/500mg SR tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Gleways M 2mg/500mg Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Yes, Gleways M 2mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gleways M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Gleways M 2mg/500mg Table...
52
MRP 60
13% off